Company Monitoring Page for Hikma

latest headlines for company on cafepharma

Merck’s Bridion Could Face Generic Pressure from Hikma Ahead of Patent Expiry Date
BioSpace
Tue, 02/27/24 - 10:18 am
Tags:
Merck, patents, Hikma, Bridion, muscle relaxants, generics
Ad firm Publicis, drugmaker Hikma settle US opioid cases for $500 million
Reuters
Thu, 02/1/24 - 10:58 pm
Tags:
Publicis, Hikma, opioids, opioid crisis, legal
In antitrust suit, Hikma says Amarin locked up exclusive supply deals to shut out Vascepa generics
Fierce Pharma
Fri, 02/24/23 - 08:55 am
Tags:
Amarin, Hikma, legal, antitrust, generics, Vascepa
Digital health firm Altibbi raises $44m in round backed by Hikma
Pharmaforum
Mon, 03/28/22 - 07:53 pm
Tags:
Altibbi, Hikma, digital health, funding, telehealth
ESC: Amarin touts Vascepa's ability to reduce repeat heart problems as it fights generic with 'skinny label' claim
Fierce Pharma
Mon, 08/23/21 - 11:32 pm
Tags:
Amarin, Vascepa, Hikma
FDA approves the first generic for Amarin's Vascepa — but is a launch imminent?
Endpoints
Fri, 05/22/20 - 11:03 am
Tags:
FDA, Amarin, Vascepa, Hikma, generics
Chasing Mylan, Hikma tries again with rejected generic Advair in US
Pharmaforum
Wed, 11/27/19 - 10:47 am
Tags:
Hikma, FDA, generics, GSK, Advair, asthma, COPD
Hikma Pharmaceuticals acquires manufacturing platform, two pipeline products from Insys Therapeutics
Stockmarket Wire
Fri, 08/9/19 - 10:42 am
Tags:
Hikma, INSYS Therapeutics, M&A, drug manufacturing
GSK wins new reprieve as Hikma's generic Advair delayed again
Yahoo/Reuters
Tue, 03/13/18 - 11:45 am
Tags:
GSK, Hikma, generics, Advair
Drugmaker Hikma's U.S. unit raises medicine prices: Financial Times
Reuters
Tue, 08/22/17 - 12:07 am
Tags:
Hikma, drug pricing, West-Ward Pharmaceuticals
Glaxo scores again as FDA strikes down would-be Advair copycats Hikma, Vectura
Fierce Pharma
Thu, 05/11/17 - 11:49 am
Tags:
GSK, FDA, Advair, Hikma, Vectura
Jazz Pharmaceuticals stock surges 7% on settlement with Hikma over generic drug
Marketwatch
Thu, 04/6/17 - 09:36 am
Tags:
Jazz Pharmaceuticals, Hikma, generics, Xyrem, narcolepsy
Hikma to buy Boehringer's U.S. generic drug business for $2.65 billion
Yahoo/Reuters
Tue, 07/28/15 - 10:04 am
Tags:
Hikma, Boehringer Ingelheim, generics, M&A
Boehringer charges ahead with sale of U.S. generics biz with bids from Hikma, Mallinckrodt
Fierce Pharma
Tue, 06/30/15 - 11:14 am
Tags:
Boehringer Ingelheim, generics, Hikma, Mallinckrodt, Perrigo Company, M&A
Mylan said to be eyeing a $7B-plus bid for rising star Hikma
Fierce Pharma
Wed, 01/28/15 - 01:14 pm
Tags:
Mylan Labs, M&A, Hikma
Hikma Pharmaceuticals receives warning over Portugal facility
Proactive Investors, UK
Sat, 10/25/14 - 11:01 am
Tags:
Hikma
Boehringer Ingelheim to sell US injectable generics business to Hikma for up to $300 million
First Word Pharma
Wed, 05/28/14 - 10:07 am
Tags:
Boehringer Ingelheim, Hikma, injectables, M&A
Hikma Has Up to $600 Million for Acquisitions, Darwazah Says
Bloomberg
Sun, 05/26/13 - 11:19 am
Tags:
Hikma
Hikma to Keep Injectable-Drug Unit After Completing Review
Bloomberg
Wed, 04/17/13 - 11:04 am
Tags:
injectables, Hikma, Amgen, Novartis
Glaxo, Pfizer Suit Claims Hikma Infringes Argatroban Patent
Bloomberg
Wed, 04/4/12 - 08:29 am
Tags:
GSK, patents, Argatroban, Pfizer, Hikma

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.